Miv Therapeutics, Inc. (IVT) Reports Q3 EPS of $0.06
Get Alerts IVT Hot Sheet
Join SI Premium – FREE
Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of $0.06. Revenue for the quarter came in at $50.89 million.
GUIDANCE:
Miv Therapeutics, Inc. sees FY2021 EPS of ($0.20)-($0.16).
For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share